Literature DB >> 11695

Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice.

E S Kleinerman, C A Daniels, R P Polisson, R Snyderman.   

Abstract

To better define the mechanisms by which viruses depress immune function, the effect of influenza infection on the ability of macrophages to accumulate at sites of inflammation was determined. Mice were inoculated with virus, and their inflammatory response measured in vivo by counting the number of leukocytes which accumulated in the peritoneal cavity 2 days after an intraperitoneal injection of phytohemagglutinin. Mice infected with influenza had a 57% and 65% depression of total leukocyte and macrophage accumulation, respectively, as compared to the response of uninfected mice. In contrast, bacterial pneumonia did not produce a decrease in the macrophage response. This indicated that the depression was produced by the virus infection rather than being a nonspecific phenomenon accompanying any inflammatory focus in the lung. The in vitro chemotactic responsiveness of normal peritoneal macrophages incubated with infectious influenza virus was 53% of normal. These experiments suggest that influenza infection may depress a host's ability to mobilize macrophages to inflammatory sites in vivo by inhibiting their chemotactic responsiveness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11695      PMCID: PMC2032573     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza.

Authors:  C M MARTIN; C M KUNIN; L S GOTTLIEB; M FINLAND
Journal:  AMA Arch Intern Med       Date:  1959-04

3.  Studies on the soluble antigen of influenza virus. I. The release of S antigen from elementary bodies by treatment with ether.

Authors:  W HENLE; F S LIEF
Journal:  Virology       Date:  1956-12       Impact factor: 3.616

4.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis.

Authors:  F T Willems; J L Melnick; W E Rawls
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

6.  Depressed monocyte chemotaxis during acute influenza infection.

Authors:  E S Kleinerman; R Snyderman; C A Daniels
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

7.  Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.

Authors:  R Snyderman; M C Pike; B L Blaylock; P Weinstein
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.

Authors:  R Snyderman; M C Pike; D McCarley; L Lang
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

9.  Immunosuppression during influenza virus infection.

Authors:  G B Kantzler; S F Lauteria; C L Cusumano; J D Lee; R Ganguly; R H Waldman
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

10.  Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.

Authors:  R Snyderman; J K Phillips; S E Mergenhagen
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Mechanisms of virus-induced immune suppression.

Authors:  M A Wainberg; E L Mills
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

2.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

3.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

4.  Pulmonary inflammatory responses during viral pneumonia and secondary bacterial infection.

Authors:  G A Warr; G J Jakab
Journal:  Inflammation       Date:  1983-06       Impact factor: 4.092

Review 5.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

6.  Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.

Authors:  Janice L Speshock; Nicole Doyon-Reale; R Rabah; Melody N Neely; Paul C Roberts
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.

Authors:  K N Masihi; W Lange; B Rohde-Schulz; L Chedid; M Jolivet
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 9.  A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.

Authors:  W D Yates
Journal:  Can J Comp Med       Date:  1982-07

10.  Depression of chemiluminescence during dengue virus infection of mice: role of cytokines.

Authors:  R Dhawan; U C Chaturvedi; K N Mashihi; P Chaturvedi; R Mukherjee
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.